Category: SiemensSyndicate content

JNJ looks to bolster "subscale" cardiovascular business | The week in medtech M&A

July 23, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere; Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Could Medtronic-Covidien deal get caught in anti-inversion legislation?; Siemens sells clinical microbiology biz to Beckman Coulter

Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere

July 16, 2014 by Brad Perriello

YYmeta

Siemens sells clinical microbiology biz to Beckman Coulter

July 17, 2014 by Arezu Sarvestani

Beckman Coulter picks up Siemens Healthcare Diagnostics' clinical microbiology business in a closed-doors deal.

Siemens sells clinical microbiology biz to Beckman Coulter

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Siemens Healthcare spinout chatter ramps up | MassDevice.com On Call

July 10, 2014 by Brad Perriello

Siemens is reportedly investigating a spinout of its Siemens Healthcare division's IT unit, which could be worth more than $1 billion.

MassDevice.com On Call

Chatter about a possible spinout for Siemens Healthcare (NYSE:SI) ramped up yesterday on a report from "2 people familiar with the plans" who said the German conglomerate is actively investigating a possible sale of its hospital database and IT business.

Press Release: Siemens files PMA for digital breast tomosynthesis

June 27, 2014 by Arezu Sarvestani

Press Release: Siemens files PMA for digital breast tomosynthesis

MALVERN, Pa. -- Siemens Healthcare has announced that it recently submitted to the U.S. Food and Drug Administration (FDA) its premarket approval application (PMA) for the MAMMOMAT Inspiration® with Breast Tomosynthesis option.

Siemens seeks FDA approval for next-gen mammograms with tomosynthesis

June 27, 2014 by Arezu Sarvestani

Siemens files a premarket approval application to add 3D breast imaging to its Mammomat Inspiration digital mammograms.

Siemens seeks FDA approval for 3D mammograms

Healthcare giant Siemens (NYSE:SI) this week filed its premarket approval application to get the FDA's OK to add a tomosynthesis option to its Mammomat Inspiration mammography system.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Is Siemens Healthcare headed for a spinout?

May 7, 2014 by Brad Perriello

A massive restructuring at Siemens aims to establish its healthcare business, which posted fiscal 2nd-quarter profit growth of 19%, as a stand-alone division could be the 1st step toward a spinout for Siemens Healthcare.

Is Siemens Healthcare headed for a spinout?

Siemens (NYSE:SI) unveiled a massive reorganization today that could be the 1st step toward a spinout for its healthcare business, which posted 19% profit growth during Siemens' fiscal 2nd quarter.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Rumor mill: Is Siemens about to cut 10k workers and flatten its business? | MassDevice.com On Call

May 1, 2014 by Arezu Sarvestani

German media reports that Siemens is about to announce a major restructuring that will flatten its business and result in as many as 10,000 layoffs.

MassDevice.com On Call

MASSDEVICE ON CALL — Siemens (NYSE:SI) has yet to comment on German media reports that the company is about to undergo a major evolution.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp